Published 2004 | Version v1
Publication

The role of alpha-interferon in chronic myelogenous leukaemia in imatinib era.

Description

The introduction of tyrosine kinase inhibition Imatinib in the treatment of CML has revolutionized the history of the disease making obsolete all the previous therapies; however, in selected cases, old drugs retain their value.

Additional details

Created:
April 14, 2023
Modified:
December 1, 2023